An outside vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) today voted to recommend the single-dose Johnson & Johnson COVID-19 vaccine after discussing study findings and policy and clinical considerations. Their interim recommendation, moving a third vaccine option just a step away from distribution, comes on the heels of the Food

The Food and Drug Administration (FDA) today issued an emergency use authorization (EUA) for the Johnson & Johnson COVID-19 vaccine, giving the United States a third vaccine to fight the pandemic—one that offers an easier, one-dose option. The formal announcement follows yesterday’s unanimous recommendation from the FDA’s outside advisory panel, the Vaccines and Related Biological

The New England Journal of Medicine yesterday published two studies on the effectiveness of the interleukin-6 receptor antagonists tocilizumab and sarilumab in severely ill adult COVID-19 patients, one finding a benefit to a combination of the two drugs and the other showing no benefit with tocilizumab alone. Early treatment with combo may be key The

“We may be done with the virus, but clearly the virus is not done with us.” That was the message from Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky, MD, MPH, today during a White House COVID-19 briefing. Citing the rising prevalence of B117 cases across the country, Walensky said that despite positive,

SARS-CoV-2 reinfects 5 in nursing home, causing worse disease, 1 death Five residents of a skilled nursing facility in Kentucky were likely reinfected with COVID-19, and the disease was worse the second time, with one patient dying, according to today’s Morbidity and Mortality Weekly Report (MMWR). Between the two outbreaks, which were reported in July

From its first human case in 1952 until just a few years ago, the Zika virus had affected relatively few people in Africa and Asia and was typically accompanied by mild symptoms: fever, body aches, rash, pink eye. Most people didn’t have any symptoms. But when it first appeared in the Americas in 2015 and

Two new studies detail unique signs and symptoms in US children and teens with the rare but severe coronavirus-related multisystem inflammatory syndrome in children (MIS-C), helping distinguish it from severe COVID-19. Age, race, organ system involvement The first study, a case series led by researchers from the US Centers for Disease Control and Prevention published

Danish study finds link between community C diff, proton pump inhibitors A nationwide study in Denmark found an association between the use of proton pump inhibitors (PPIs) and increased risk of community-associated Clostridioides difficile infections (CA-CDI), Danish researcher reported today in Clinical Infectious Diseases. For the study, researchers from Denmark’s Statens Serum Institute used the

COVID-19 antibodies may offer at least partial protection Americans with COVID-19 antibodies displayed 10-fold increased protection against infection 90 days after testing compared with those who had no antibodies, according to a study published today in JAMA Internal Medicine. The study tracked more than 50% of the commercial antibody and diagnostic tests administered in the